CGP 54626A



CGP 54626A

N H O H P O O H Cl Cl

SMILES C[C@H](NC[C@H](O)CP(=O)(O)CC1CCCCC1)c1ccc(Cl)c(Cl)c1
InChIKey JGGVBBYJRQOPPA-BBRMVZONSA-N

Chemical Properties

Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 8
Molecular weight (Da) 407.1


Bioactivities

CGP 54626A

N H O H P O O H Cl Cl

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV


Compound is not listed as a drug.